Loading clinical trials...
Loading clinical trials...
A Phase I, Open-label to the Route of Administration, Single-blind to the ID Doses, Randomised, Active-controlled, Parallel Study to Evaluate the Safe Usability of 4Fluart ID Suspension for Injection in Adult Subjects
Conditions
Interventions
4Fluart ID suspension for injection study drug 1 µg/0.1 ml, influenza vaccine (whole virion, inactivated, adjuvanted)
4Fluart ID suspension for injection study drug 2 µg/0.1 ml, influenza vaccine (whole virion, inactivated, adjuvanted)
+1 more
Locations
1
Hungary
Drug Research Center
Balatonfüred, Veszprém megye, Hungary
Start Date
January 31, 2018
Primary Completion Date
April 3, 2018
Completion Date
April 3, 2018
Last Updated
March 3, 2021
NCT04682444
NCT04431050
NCT02387294
NCT03572491
NCT01651104
NCT01879540
Lead Sponsor
Fluart Innovative Vaccine Ltd, Hungary
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions